Page 11 - Bryan Dunn News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Maine-based real estate developer Taylor Perkins and his holding company, The Surf Company LLC, have announced its partnership with Life House to operate its two beachfront hotels in York, Maine. The portfolio, which encompasses nearly 140 keys on the beach in York, represents Life House’s first projects in Maine, with the intention to expand their partnership with The Surf Company up and down the New England coast.

PEMBINE, Wis.--(BUSINESS WIRE)--Nov 5, 2021--

TICOVAC™ may help reduce the risk of TBE for people traveling to endemic areas, potentially including military personnel serving in these locations Pfizer Inc. today announced that the U.S. Food and Drug Administration has approved TICOVAC™ vaccine) for active immunization to prevent TBE in individuals 1 year of age and older. 1 TICOVAC™ is the only FDA-approved vaccine to help protect U.S. adults and children ...

Pfizer Provides Update on U.S. FDA Review of Abrocitinib and XELJANZ® Filings Pfizer Inc. announced today that the U.S. Food and Drug Administration has notified the company that it will not meet the Prescription Drug User Fee Act goal dates for the New Drug Application for abrocitinib for the treatment of adults and adolescents with moderate to severe atopic dermatitis and the supplemental New Drug Application for XELJANZXELJANZ XR for the treatment of adults with active ankylosing … Pfizer Inc. (NYSE: PFE) announced today that the U.S. Food and Drug Administration (FDA) has notified the...

Press release content from Globe Newswire. The AP news staff was not involved in its creation. Valneva and Pfizer Complete Recruitment for Phase 2 Trial of Lyme Disease Vaccine Candidate VALNEVAJuly 19, 2021 GMT Saint-Herblain (France) and New York, NY, July 19, 2021 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company focused on the development and commercialization of prophylactic vaccines for infectious diseases with significant unmet medical need, and Pfizer Inc. (NYSE: PFE), today announced that they have completed recruitment for the Phase 2 trial, VLA15-221, ...